214 related articles for article (PubMed ID: 35140718)
1. Autocrine/Paracrine Loop Between SCF
Annese T; Tamma R; Bozza M; Zito A; Ribatti D
Front Immunol; 2022; 13():794974. PubMed ID: 35140718
[TBL] [Abstract][Full Text] [Related]
2. Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.
Giehl KA; Nägele U; Volkenandt M; Berking C
J Cutan Pathol; 2007 Jan; 34(1):7-14. PubMed ID: 17214848
[TBL] [Abstract][Full Text] [Related]
3. Expression of Stem Cell Factor in Feline Mast Cell Tumour.
Sakurai M; Iwasa R; Sakai Y; Chambers JK; Uchida K; Morimoto M
J Comp Pathol; 2018 Aug; 163():6-9. PubMed ID: 30213375
[TBL] [Abstract][Full Text] [Related]
4. A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.
Mazzoldi EL; Pavan S; Pilotto G; Leone K; Pagotto A; Frezzini S; Nicoletto MO; Amadori A; Pastò A
Cell Death Dis; 2019 May; 10(6):412. PubMed ID: 31138788
[TBL] [Abstract][Full Text] [Related]
5. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
[TBL] [Abstract][Full Text] [Related]
6. Internalization of Kit together with stem cell factor on human fetal liver-derived mast cells: new protein and RNA synthesis are required for reappearance of Kit.
Shimizu Y; Ashman LK; Du Z; Schwartz LB
J Immunol; 1996 May; 156(9):3443-9. PubMed ID: 8617971
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway.
Hollenbeck ST; Sakakibara K; Faries PL; Workhu B; Liu B; Kent KC
J Surg Res; 2004 Aug; 120(2):288-94. PubMed ID: 15234225
[TBL] [Abstract][Full Text] [Related]
8. Stem cell factor contributes to tumorigenesis of mast cells via an autocrine/paracrine mechanism.
Amagai Y; Tanaka A; Matsuda A; Jung K; Ohmori K; Matsuda H
J Leukoc Biol; 2013 Feb; 93(2):245-50. PubMed ID: 23125456
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours.
Takahashi H; Saitoh K; Kishi H; Parsons PG
Virchows Arch; 1995; 427(3):283-8. PubMed ID: 7496598
[TBL] [Abstract][Full Text] [Related]
10. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
11. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
12. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
13. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas.
Ashida A; Takata M; Murata H; Kido K; Saida T
Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443
[TBL] [Abstract][Full Text] [Related]
14. Transient production of stem cell factor in dermal cells but increasing expression of Kit receptor in mast cells during normal wound healing.
Huttunen M; Naukkarinen A; Horsmanheimo M; Harvima IT
Arch Dermatol Res; 2002 Oct; 294(7):324-30. PubMed ID: 12373338
[TBL] [Abstract][Full Text] [Related]
15. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.
Krasagakis K; Fragiadaki I; Metaxari M; Krüger-Krasagakis S; Tzanakakis GN; Stathopoulos EN; Eberle J; Tavernarakis N; Tosca AD
J Cell Physiol; 2011 Apr; 226(4):1099-109. PubMed ID: 20857409
[TBL] [Abstract][Full Text] [Related]
16. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors.
Turner AM; Zsebo KM; Martin F; Jacobsen FW; Bennett LG; Broudy VC
Blood; 1992 Jul; 80(2):374-81. PubMed ID: 1378316
[TBL] [Abstract][Full Text] [Related]
17. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
Montone KT; van Belle P; Elenitsas R; Elder DE
Mod Pathol; 1997 Sep; 10(9):939-44. PubMed ID: 9310959
[TBL] [Abstract][Full Text] [Related]
18. Production of stem cell factor in canine mast cell tumors.
Amagai Y; Tanaka A; Jung K; Matsuda A; Oida K; Nishikawa S; Jang H; Ishizaka S; Matsuda H
Res Vet Sci; 2014 Feb; 96(1):124-6. PubMed ID: 24269079
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic modulation of KIT ligand in melanocytic disorders with implications for mast cell diseases.
Sevilla A; Grichnik J
Exp Dermatol; 2024 May; 33(5):e15091. PubMed ID: 38711220
[TBL] [Abstract][Full Text] [Related]
20. Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit.
Lennartsson J; Shivakrupa R; Linnekin D
J Biol Chem; 2004 Oct; 279(43):44544-53. PubMed ID: 15308671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]